Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4963124 | 6026198 | I | 4963124-6 | 20060317 | 20060331 | EXP | 2006-00647 | MILLENIUM PHARMACEUTICALS INC. | N | 20060327 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4963124 | 1007131917 | PS | VELCADE | 1 | INTRAVENOUS BOLUS | IV BOLUS | U | U | 21602 | ||
| 4963124 | 1007173162 | SS | DOXORUBICIN(DOXORUBICIN) | 2 | INTRAVENOUS | 30,00 MG/M2, INTRAVENOUS | U | U |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4963124 | 1007131917 | HODGKIN'S DISEASE |
| 4963124 | 1007173162 | HODGKIN'S DISEASE |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4963124 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 4963124 | DISEASE PROGRESSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4963124 | HP |
| 4963124 | LIT |
| 4963124 | SDY |
Therapies reported
| no results found |